首页> 美国卫生研究院文献>Open Forum Infectious Diseases >1261. Antimicrobial Activity of Aztreonam-Avibactam against Gram-negative Bacteria Isolated from Patients Hospitalized with Pneumonia in Europe Latin America and Asia in 2019

【2h】

1261. Antimicrobial Activity of Aztreonam-Avibactam against Gram-negative Bacteria Isolated from Patients Hospitalized with Pneumonia in Europe Latin America and Asia in 2019

机译：1261. 2019年在欧洲拉丁美洲和亚洲患有住院患者患者患者患者患者患者患者患者患者患者抗菌抗菌活性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Aztreonam (ATM) is a monobactam stable to hydrolysis by metallo-β-lactamases (MBL). Avibactam (AVI) is a non-β-lactam β-lactamase inhibitor that inhibits serine carbapenemases (CPEs), such as ESBLs, KPCs, AmpC, and some OXAs. ATM-AVI is under clinical development for treatment of serious infections caused by Gram-negative bacteria (GNB), including MBL-producers.

机译：AztReonam（ATM）是由金属-β-内酰胺酶（MBL）水解的单离药稳定。 Avibactam（AVI）是非β-内酰胺β-内酰胺酶抑制剂，其抑制丝氨酸碳结构酶（CPE），例如ESBLS，KPC，AMPC和一些牛粪。 ATM-AVI受到临床开发，用于治疗由革兰氏阴性细菌（GNB）引起的严重感染，包括MBL-生产商。

著录项

期刊名称 Open Forum Infectious Diseases
作者
Helio S Sader; Mariana Castanheira; Cecilia G Carvalhaes; Timothy B Doyle; Rodrigo E Mendes;
展开▼
作者单位

展开▼
年(卷),期 2020(7),Suppl 1
年度 2020
页码 S647
总页数 1
原文格式 PDF
正文语种
中图分类病毒传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America [J] . Helio S. Sader, Robert K. Flamm, Jennifer M. Streit, International journal of infectious diseases : . 2018,第Supplementa1期

机译：头孢洛林和比较剂对从欧洲，亚洲和拉丁美洲的社区获得性细菌性肺炎患者中分离出的生物体的抗菌活性进行了测试
2. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in US Medical Centers, 2011 to 2015 [J] . Sader Helio S., Castanheira Mariana, Flamm Robert K. Antimicrobial agents and chemotherapy. . 2017,第4期

机译：Ceftazidime-Avibactam对来自肺炎患者患者患者患者患者的抗菌活性，在2011年至2015年
3. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000). [J] . Gales AC, Sader H HS, Jones RN Diagnostic microbiology and infectious disease . 2002,第3期

机译：从拉丁美洲怀疑肺炎住院的患者中分离出的呼吸道病原体：发生频率和抗菌素敏感性分布：SENTRY抗菌素监测计划（1997-2000）的结果。
4. Antagonistic activity of isolated lactic acid bacteria from Pliek U against gram-negative bacteria Escherichia coli ATCC 25922 [C] . A. A. Kiti, I. Jamilah, H. Rusmarilin Electronic and Green Materials International Conference . 2017

机译：来自Pliek U抗革兰阴性细菌大肠杆菌ATCC 25922的分离乳酸菌的拮抗活性
5. Antimicrobial activity of human leukocyte defensin HNP-4 against Gram-negative bacteria. [D] . Hilal, George E. 2008

机译：人白细胞防御素HNP-4对革兰氏阴性菌的抗菌活性。
6. 1472. Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated from Patients Hospitalized with Bacterial Pneumonia in the United States Western Europe and Eastern Europe: Results from the SENTRY Program (2016-2019) [O] . Helio S Sader, Cecilia G Carvalhaes, Jennifer M Streit, 2020

机译：1472.从美国西欧和东欧住院的患者分离的患者中分离的细菌的发生频率和抗菌易感性：Sentry计划的结果（2016-2019）
7. 1261. Antimicrobial Activity of Aztreonam-Avibactam against Gram-negative Bacteria Isolated from Patients Hospitalized with Pneumonia in Europe, Latin America, and Asia in 2019 [O] . Helio S Sader, Mariana Castanheira, Cecilia G Carvalhaes, 2020

机译：1261. 2019年在欧洲，拉丁美洲和亚洲患有住院患者患者患者患者患者患者患者患者患者患者抗菌抗菌活性

1261. Antimicrobial Activity of Aztreonam-Avibactam against Gram-negative Bacteria Isolated from Patients Hospitalized with Pneumonia in Europe Latin America and Asia in 2019

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅